WO2022031998A3 - Procédé de préparation d'intermédiaires utiles dans la préparation de composés qui modulent l'épissage - Google Patents

Procédé de préparation d'intermédiaires utiles dans la préparation de composés qui modulent l'épissage Download PDF

Info

Publication number
WO2022031998A3
WO2022031998A3 PCT/US2021/044794 US2021044794W WO2022031998A3 WO 2022031998 A3 WO2022031998 A3 WO 2022031998A3 US 2021044794 W US2021044794 W US 2021044794W WO 2022031998 A3 WO2022031998 A3 WO 2022031998A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
compounds
modulate splicing
intermediates useful
mrna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2021/044794
Other languages
English (en)
Other versions
WO2022031998A2 (fr
Inventor
Michael Luzzio
Tiansheng Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Skyhawk Therapeutics Inc
Original Assignee
Skyhawk Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Skyhawk Therapeutics Inc filed Critical Skyhawk Therapeutics Inc
Publication of WO2022031998A2 publication Critical patent/WO2022031998A2/fr
Publication of WO2022031998A3 publication Critical patent/WO2022031998A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22Tin compounds
    • C07F7/2208Compounds having tin linked only to carbon, hydrogen and/or halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des procédés de préparation de composés utiles dans la préparation de composés modulateurs d'épissage de petites molécules qui modulent l'épissage d'ARNm, tels que des pré-ARNm, codés par des gènes, et des composés utilisés dans de tels procédés.
PCT/US2021/044794 2020-08-05 2021-08-05 Procédé de préparation d'intermédiaires utiles dans la préparation de composés qui modulent l'épissage Ceased WO2022031998A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063061744P 2020-08-05 2020-08-05
US63/061,744 2020-08-05
US202163161233P 2021-03-15 2021-03-15
US63/161,233 2021-03-15

Publications (2)

Publication Number Publication Date
WO2022031998A2 WO2022031998A2 (fr) 2022-02-10
WO2022031998A3 true WO2022031998A3 (fr) 2022-03-17

Family

ID=80120143

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2021/044794 Ceased WO2022031998A2 (fr) 2020-08-05 2021-08-05 Procédé de préparation d'intermédiaires utiles dans la préparation de composés qui modulent l'épissage

Country Status (1)

Country Link
WO (1) WO2022031998A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7551629B2 (ja) 2019-02-05 2024-09-17 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
WO2020163405A1 (fr) * 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Procédés et compositions pour moduler l'épissage
JP7603594B2 (ja) 2019-02-06 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
JP7603595B2 (ja) 2019-02-06 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
MX2023001558A (es) * 2020-08-05 2023-04-26 Skyhawk Therapeutics Inc Composiciones para modular el corte y empalme.
GB202106871D0 (en) * 2021-05-13 2021-06-30 Addex Pharmaceuticals Sa Novel compounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160280721A1 (en) * 2013-11-03 2016-09-29 The Board Of Trustees Of The University Of Illinois Cross-coupling of unactivated secondary boronic acids
WO2019028440A1 (fr) * 2017-08-04 2019-02-07 Skyhawk Therapeutics, Inc. Méthodes et compositions permettant de moduler l'épissageé
WO2019191229A1 (fr) * 2018-03-27 2019-10-03 Ptc Therapeutics, Inc. Composés permettant de traiter la maladie de huntington

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160280721A1 (en) * 2013-11-03 2016-09-29 The Board Of Trustees Of The University Of Illinois Cross-coupling of unactivated secondary boronic acids
WO2019028440A1 (fr) * 2017-08-04 2019-02-07 Skyhawk Therapeutics, Inc. Méthodes et compositions permettant de moduler l'épissageé
WO2019191229A1 (fr) * 2018-03-27 2019-10-03 Ptc Therapeutics, Inc. Composés permettant de traiter la maladie de huntington

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE PubChem substance ANONYMOUS : "SID 151978989 ", XP055920099 *
ONO ET AL.: "Regioselective Preparation of Allylic Sulfones by Palladium-Catalyzed Reactions of Allylic Nitro Compounds with Sodium Benzenesulfinate", BULL. CHEM. SOC. JPN., vol. 59, 1986, pages 405 - 410, XP055915474 *

Also Published As

Publication number Publication date
WO2022031998A2 (fr) 2022-02-10

Similar Documents

Publication Publication Date Title
WO2022031998A3 (fr) Procédé de préparation d&#39;intermédiaires utiles dans la préparation de composés qui modulent l&#39;épissage
MX2020005748A (es) Metodos y composiciones para modular el empalme.
EP4111448A4 (fr) Procédé, système et support de recommandation et de composition de musique affectives
WO2021207530A8 (fr) Composés et procédés de modulation de l&#39;épissage
MX2022010683A (es) Compuestos y metodos para modular el empalme.
MX2023001558A (es) Composiciones para modular el corte y empalme.
AU2020330570A8 (en) Process of making CFTR modulators
EP4149485A4 (fr) Formulations d&#39;arn pour une distribution de volume élevé, et leurs méthodes d&#39;utilisation pour traiter la covid-19
MX2022010637A (es) Derivados de piridazina para modular el empalme de acidos nucleicos.
WO2022094299A3 (fr) Anticorps multispécifiques pour le ciblage de cd28 et pd-l1 et leurs procédés d&#39;utilisation
WO2019178364A3 (fr) Molécules multifonctionnelles et utilisations associées
WO2020227758A8 (fr) Modulateurs et modulation du récepteur pour l&#39;arn de produits finaux de glycation avancée
WO2019241802A3 (fr) Procédés d&#39;inhibition de cellules prolifératives
WO2020086144A3 (fr) APPLICATIONS DE CRISPRi DANS L&#39;INGÉNIERIE MÉTABOLIQUE À HAUT RENDEMENT
EP4484402A3 (fr) Procédés de fabrication de modulateurs du régulateur de conductance transmembranaire de la fibrose kystique
WO2021138474A3 (fr) Molécules d&#39;anticorps anti-tcr et leurs utilisations
WO2020172596A8 (fr) Molécules d&#39;anticorps anti-tcr et leurs utilisations
MX2022010681A (es) Compuestos y metodos para modular el empalme.
WO2020205626A8 (fr) Modulateurs d&#39;interactions de protéine de surface cellulaire et procédés et compositions associés à ceux-ci
WO2023086938A3 (fr) Nucléases de type v
WO2020028269A3 (fr) Molécules multispécifiques de liaison aux treg
ZA202304787B (en) Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules
MX2025006646A (es) Moleculas de union al antigeno de gp130
WO2024137700A3 (fr) Molécules d&#39;acide polynucléique ciblant l&#39;agt et leurs utilisations
AU2020298092A8 (en) Process for the preparation of CIC-1 chloride channel inhibitors

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21853192

Country of ref document: EP

Kind code of ref document: A2